150 related articles for article (PubMed ID: 35184152)
21. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
22. [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus].
Du J; Yu WJ; Guo RP; Su J
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):621-626. PubMed ID: 35785832
[No Abstract] [Full Text] [Related]
23. Combined deep penetrating nevi of the conjunctiva are relatively common lesions characterised by BRAFV600E mutation and activation of the beta catenin pathway: a clinicopathological analysis of 34 lesions.
Šekoranja D; Vergot K; Hawlina G; Pižem J
Br J Ophthalmol; 2020 Jul; 104(7):1016-1021. PubMed ID: 31558492
[TBL] [Abstract][Full Text] [Related]
24. Combination of Congenital and Deep Penetrating Nevus by Acquisition of β-Catenin Activation.
Garrido MC; Nájera L; Navarro A; Huerta V; Garrido E; Rodriguez-Peralto JL; Requena L
Am J Dermatopathol; 2020 Dec; 42(12):948-952. PubMed ID: 32568834
[TBL] [Abstract][Full Text] [Related]
25. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
26. Combined activation of MAP kinase pathway and β-catenin signaling cause deep penetrating nevi.
Yeh I; Lang UE; Durieux E; Tee MK; Jorapur A; Shain AH; Haddad V; Pissaloux D; Chen X; Cerroni L; Judson RL; LeBoit PE; McCalmont TH; Bastian BC; de la Fouchardière A
Nat Commun; 2017 Sep; 8(1):644. PubMed ID: 28935960
[TBL] [Abstract][Full Text] [Related]
27. Preferentially Expressed Antigen in Melanoma Immunostaining in a Series of Melanocytic Neoplasms.
Googe PB; Flanigan KL; Miedema JR
Am J Dermatopathol; 2021 Nov; 43(11):794-800. PubMed ID: 33989214
[TBL] [Abstract][Full Text] [Related]
28. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
29. Deep penetrating nevus: a review.
Luzar B; Calonje E
Arch Pathol Lab Med; 2011 Mar; 135(3):321-6. PubMed ID: 21366455
[TBL] [Abstract][Full Text] [Related]
30. Modern Concepts in Melanocytic Tumors.
Fernandez-Flores A
Actas Dermosifiliogr; 2023 May; 114(5):402-412. PubMed ID: 36649787
[TBL] [Abstract][Full Text] [Related]
31. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
[TBL] [Abstract][Full Text] [Related]
32. Ataxia telangiectasia-mutated gene is a possible biomarker for discrimination of infiltrative deep penetrating nevi and metastatic vertical growth phase melanoma.
Roesch A; Becker B; Bentink S; Spang R; Vogl A; Hagen I; Landthaler M; Vogt T
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2486-90. PubMed ID: 18006941
[TBL] [Abstract][Full Text] [Related]
33. p16 Range of expression in dermal predominant benign epithelioid and spindled nevi and melanoma.
Oaxaca G; Billings SD; Ko JS
J Cutan Pathol; 2020 Sep; 47(9):815-823. PubMed ID: 32330325
[TBL] [Abstract][Full Text] [Related]
34. CTNNB1-mutated melanocytic lesions with DPN like features: a distinct subtype of melanocytic tumors? A report of two cases.
Teunissen BT; Knuiman GJ; Eijkelenboom A; Wauters CAP; Wouda S; Blokx WAM
Virchows Arch; 2018 Apr; 472(4):683-687. PubMed ID: 29086002
[No Abstract] [Full Text] [Related]
35. NGS-Based Analysis of Atypical Deep Penetrating Nevi.
Manca A; Sini MC; Cesinaro AM; Portelli F; Urso C; Lentini M; Cardia R; Alos L; Cook M; Simi S; Paliogiannis P; De Giorgi V; Cossu A; Palmieri G; Massi D
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205480
[TBL] [Abstract][Full Text] [Related]
36. Histologic mimics of malignant melanoma.
Bsirini C; Smoller BR
Singapore Med J; 2018 Nov; 59(11):602-607. PubMed ID: 29774360
[TBL] [Abstract][Full Text] [Related]
37. Nevus, melanoma, or something else? Mesenchymal neoplasms with melanocytic differentiation.
Evangelou Z; Linos K
J Cutan Pathol; 2022 Aug; 49(8):747-759. PubMed ID: 35338512
[TBL] [Abstract][Full Text] [Related]
38. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
39. Deep penetrating nevus.
Mehregan DA; Mehregan AH
Arch Dermatol; 1993 Mar; 129(3):328-31. PubMed ID: 8447669
[TBL] [Abstract][Full Text] [Related]
40. Deep penetrating nevus.
Seab JA; Graham JH; Helwig EB
Am J Surg Pathol; 1989 Jan; 13(1):39-44. PubMed ID: 2909196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
